PAIM
IRMD icon

Punch & Associates Investment Management’s iRadimed IRMD Stock Holding History

Punch & Associates Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Hold
17,000
– – 0.09% 137
2025
Q4 		$1.65M Hold
17,000
– – 0.1% 134
2025
Q3 		$1.21M Buy
+17,000
New +$1.13M 0.07% 141

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Punch & Associates Investment Management's IRMD Position: Q1 2026 in Review

Punch & Associates Investment Management held its iRadimed (IRMD) position steady in Q1 2026 at 17,000 shares worth $1.64M. The position accounts for 0.09% of the portfolio, ranked #137.

Punch & Associates Investment Management first reported a position in IRMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.65M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Punch & Associates Investment Management held 17,000 shares of iRadimed worth $1.64M as of Q1 2026.
  • Punch & Associates Investment Management left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up 0.09% of Punch & Associates Investment Management's portfolio in Q1 2026, its #137 holding.
  • Punch & Associates Investment Management first reported a position in iRadimed in Q3 2025 and has held it in 3 quarters since.
  • Punch & Associates Investment Management's iRadimed position peaked at $1.65M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Punch & Associates Investment Management's 13F filing for Q1 2026, filed 15 May 2026.